Thursday, December 11th, 2025: Day ThreeThursday, 11 December 2025 - ET (Eastern Time, GMT-05:00)

As market mergers, joint ventures and more transform the life sciences marketplace, hear from key industry experts on what is changing and what is being forecasted as areas of interest moving forward.

• Gain shared insight and perspectives from seasoned executives in banking and private equity

• Understand market dynamics across different channels

• Focus on areas of investment for private equity and strategic acquirers

• Explore a current market update and M&A outlook

• Gain actionable insights on WAC optimization strategies, pricing governance models and access-driven pricing approaches that drive both commercial success and patient affordability

• Manage the gross-to-net bubble across diverse product portfolios including branded pharmaceuticals, generics and biosimilars to maximize financial performance

• Understand financial reporting risks associated with complex distribution channel dynamics

• Gain insight on the current status of the CMS Maximum Fair Price (MFP) for the first ten drugs selected for the Medicare Drug Price Negotiation Program scheduled to go live on January 1, 2026 and how the Medicare Transaction Facilitator (MTF) data model will operate and what stakeholders can expect from upcoming regulatory changes

• Hear more about latest NCPDP standards developments and the industry pledges for advancing interoperability within healthcare systems to improve data exchange and care coordination

• Understand stakeholder action plans for digital therapeutics integration and opportunities for expanding clinical services in pharmacy settings to enhance patient care delivery

This session provides a comprehensive overview of MFP and 340B rebate rules, focusing on their implementation and logistics. Attendees gain insights into the challenges and opportunities presented by these regulations, including the impact of WAC reductions on 340B programs. The session also explores the reimbursement landscape, addressing critical questions such as how top 10 drugs will be affected and the broader implications for healthcare providers and payers.

Transformation has become a constant in business. Yet despite their importance, nearly 85% of transformation initiatives fail. The reason isn’t a lack of strategy but the same recurring patterns. The key to making transformation work is identifying our patterns and attacking with the right pattern breakers. In Transformation Delusion, Mark Donnolo, CEO of SalesGlobe, bestselling author, and master storyteller takes us on a journey through the trajectory of transformation grief, the three major pattern repeats, and the human patterns in our businesses. He’ll challenge you recognize your patterns, stop the madness of surface-level solutions, and find your transformation solution to start making real change today.

• Understanding the stages of transformation grief

• Recognizing the patterns around problem, precedent and people

• Leveraging pattern-breaker methods you can apply right away

• Implementing the transformation drivers to set the stage, operationalize and get results